Table 3 Predictors of overall complications in hospitalized IBD patients

Age (years)

0.994

(0.972–1.015)

0.564

Gender (Male)

0.403

(0.182–0.893)

0.025*

0.449

(0.188–1.072)

0.071

BMI

1.039

(0.943–1.146)

0.441

CMV colitis

1.185

(0.556–2.524)

0.661

3.532

(1.012–12.331)

0.048*

Laboratory data

 WBC

0.964

(0.873–1.063)

0.461

 Haemoglobin

0.924

(0.788–1.083)

0.329

 CRP

1.000

(0.99–1.01)

0.978

 Albumin

1.018

(0.535–1.937)

0.956

IBD duration (months)

1.007

(0.999–1.015)

0.072

1.005

(0.997–1.013)

0.256

Clinical presentation

 Bloody stool

0.632

(0.291–1.374)

0.247

 Diarrhoea

0.499

(0.233–1.068)

0.073

 Pain

0.966

(0.456–2.044)

0.928

 Fever

0.978

(0.356–2.684)

0.965

IBD Medication

 Biological failure

3.484

(1.492–8.134)

0.004*

4.953

(1.91–12.842)

0.001*

 Biologics user

1.575

(0.707–3.509)

0.266

 5-ASA

2.153

(0.49–9.458)

0.310

 Oral prednisolone

0.684

(0.33–1.42)

0.308

 Azathioprine

0.869

(0.386–1.957)

0.735

 Antibiotics

0.592

(0.272–1.288)

0.186

Antiviral treatment ≧ 14 days

0.613

(0.268–1.402)

0.247

0.108

(0.023–0.512)

0.005*